US74587V1070
US74587V1070
Puma Biotechnology Inc
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 531.17M EUR | 414.44M EUR | 325.12M EUR | 299.93M EUR |
Enterprise Value | 425.57M EUR | 382.72M EUR | 304.88M EUR | 298.84M EUR |
Valuation Multiples | ||||
Trailing P/E | 20.18x | 15.51x | 13.33x | 10.66x |
Forward P/E | 29.4x | -- | -- | -- |
Price to Sales | 2.3x | 1.79x | 1.43x | 1.64x |
Price to Book | 3.8x | 2.99x | 2.53x | 2.3x |
EV/Revenue | 1.84x | 1.66x | 1.34x | 1.64x |
EV/EBITDA | 10.61x | 8.47x | 6.78x | 6.63x |
Price to FCF (P/FCF) | 16.36x | 10.07x | 6.07x | 7.86x |
EV/FCF | 13.11x | 9.3x | 5.69x | 7.83x |
FCF Yield | 6.11% | 9.93% | 16.49% | 12.73% |